Academic Journal
A prospective cohort study to define the clinical and pathological features of lung cancers harboring HER2 gene aberrations (the HER2-CS Study) and a phase II study of trastuzumab emtansine (recombinant) in patients with HER2-positive non-small cell lung cancer who recurred, progressed after standard chemotherapy, or were primarily refractory to standard chemotherapy
| العنوان: | A prospective cohort study to define the clinical and pathological features of lung cancers harboring HER2 gene aberrations (the HER2-CS Study) and a phase II study of trastuzumab emtansine (recombinant) in patients with HER2-positive non-small cell lung cancer who recurred, progressed after standard chemotherapy, or were primarily refractory to standard chemotherapy / HER2異常等の低頻度の分子異常を有する非小細胞肺癌の臨床病理学的特徴を明らかにするための前向き観察研究（HER2-CS Study）と標準化学療法後再発・増悪または標準化学療法不応性のHER2陽性非小細胞肺癌患者を対象としたトラスツズマブエムタンシン（遺伝子組換え）の第2相試験 |
|---|---|
| المؤلفون: | Akiko Sato, Daisuke Minnami, Kadoaki Ohashi, Katsuyuki Hotta, Katsuyuki Kiura, Masahiro Tabata, Taizo Hirata, Takashi Ninomiya, Toshio Kubo, Yuka Kato, 久保 寿夫, 二宮 崇, 佐藤 晃子, 加藤 有加, 南 大輔, 堀田 勝幸, 大橋 圭明, 平田 泰三, 木浦 勝行, 田端 雅弘 |
| المصدر: | 岡山医学会雑誌 / Okayama Igakkai Zasshi (Journal of Okayama Medical Association). 2015, 127(2):127 |
| قاعدة البيانات: | J-STAGE |
| تدمد: | 00301558 18824528 |
|---|---|
| DOI: | 10.4044/joma.127.127 |